Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
10 pending office actions • 3 clients • 10 examiners • 10 art units • 0 of 10 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days
This profile has 12 pending office actions in Biotechnology & Pharmaceuticals. Its broader record covers 74576 career applications, with a resolved allowance rate of 88.02% and an average of 3.15 office actions per allowance.
The current docket is concentrated in a biotechnology and pharmaceutical technology area. The broader prosecution figures can guide expectations about allowance outcomes and the response activity associated with allowed matters.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (10%) |
| §101 + other | 3 (30%) |
| §103 only | 2 (20%) |
| §112 only | 1 (10%) |
| Double-patenting + other | 1 (10%) |
| Multi-statute (no §101) | 2 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STEPHENS, JACQUELINE F | 1 | 75.6% | +14.9% |
| SIRCAR, ALISHA JITENDRA | 1 | 54.8% | +51.6% |
| ALLEN, SARAH ELIZABETH | 1 | 56.7% | +33.3% |
| CRAIGO, WILLIAM A | 1 | 48.9% | +38.1% |
| COUGHLIN, DANIEL F | 1 | 38.9% | +18.3% |
| BRANDT, DAVID NELSON | 1 | 70.4% | +49.7% |
| EVANS, CHRISTOPHER RYAN | 1 | 60.9% | +64.3% |
| MCCORMICK, CATHERINE LYNN | 1 | 52.3% | +39.8% |
| PLAYER, ROBERT AUSTIN | 1 | 13.6% | +34.1% |
| FLINDERS, JEREMY C | 1 | 63.5% | +17.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18658442 | DERIVATION OF ELECTRODERMAL ACTIVITY RESPONSE FROM AN ELECTROCARDIOGRAM SIGNAL | SIRCAR, ALISHA JITENDRA | 23d overdue |
| 18658102 | DISSOLUTION ADAPTER, METHOD OF MANUFACTURE THEREOF AND METHOD OF USE THEREOF | STEPHENS, JACQUELINE F | — |
| 18474544 | NASOGASTRIC DEVICE AND METHOD | BRANDT, DAVID NELSON | — |
| 18351317 | ULTRASENSITIVE SENSING METHOD FOR DETECTION OF BIOMOLECULES | EVANS, CHRISTOPHER RYAN | — |
| 18017551 | BIOMEDICAL BIG DATA ANALYSIS PROGRAM | PLAYER, ROBERT AUSTIN | — |
| 17881387 | ASSAY COMPOUND SCREENING | FLINDERS, JEREMY C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18658442 | DERIVATION OF ELECTRODERMAL ACTIVITY RESPONSE FROM AN ELECTROCARDIOGRAM SIGNAL | SIRCAR, ALISHA JITENDRA | 23d overdue |
| 18658102 | DISSOLUTION ADAPTER, METHOD OF MANUFACTURE THEREOF AND METHOD OF USE THEREOF | STEPHENS, JACQUELINE F | — |
| 18630651 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF GLYCOGEN STORAGE DISORDERS | ALLEN, SARAH ELIZABETH | — |
| 18535288 | PHOTO-CROSSLINKABLE PLANT-BASED MATERIALS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME | CRAIGO, WILLIAM A | — |
| 18285602 | FOAM BIOMATERIAL AND SYSTEMS, METHODS, AND DEVICES FOR MAKING AND USING SAME | COUGHLIN, DANIEL F | — |
| 18474544 | NASOGASTRIC DEVICE AND METHOD | BRANDT, DAVID NELSON | — |
| 18351317 | ULTRASENSITIVE SENSING METHOD FOR DETECTION OF BIOMOLECULES | EVANS, CHRISTOPHER RYAN | — |
| 18041271 | ANTI-SEED PNAS AND MICRORNA INHIBITION | MCCORMICK, CATHERINE LYNN | — |
| Client (Assignee) | Pending OAs |
|---|---|
| University of Connecticut | 8 |
| CONNECTICUT CHILDREN'S MEDICAL CENTER | 1 |
| BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 1 |
| Art Unit | Apps |
|---|---|
| 3781 | 1 |
| 3792 | 1 |
| 1637 | 1 |
| 1615 | 1 |
| 1619 | 1 |
| 3783 | 1 |
| 1677 | 1 |
| 1638 | 1 |
| 1686 | 1 |
| 1684 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18658102 | DISSOLUTION ADAPTER, METHOD OF MANUFACTURE THEREOF AND METHOD OF USE THEREOF | UNIVERSITY OF CONNECTICUT | STEPHENS, JACQUELINE F | 3781 | §102§103§112 | Non-Final OA | — | Pending | May 08, 2024 |
| 18658442 | DERIVATION OF ELECTRODERMAL ACTIVITY RESPONSE FROM AN ELECTROCARDIOGRAM SIGNAL | UNIVERSITY OF CONNECTICUT | SIRCAR, ALISHA JITENDRA | 3792 | §101§103 | Final Rejection | 23d overdue | Pending | May 08, 2024 |
| 18630651 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF GLYCOGEN STORAGE DISORDERS | UNIVERSITY OF CONNECTICUT | ALLEN, SARAH ELIZABETH | 1637 | §112 | Non-Final OA | — | Pending | Apr 09, 2024 |
| 18535288 | PHOTO-CROSSLINKABLE PLANT-BASED MATERIALS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME | UNIVERSITY OF CONNECTICUT | CRAIGO, WILLIAM A | 1615 | §102§103§112DP | Final Rejection | — | Pending | Dec 11, 2023 |
| 18285602 | FOAM BIOMATERIAL AND SYSTEMS, METHODS, AND DEVICES FOR MAKING AND USING SAME | UNIVERSITY OF CONNECTICUT | COUGHLIN, DANIEL F | 1619 | §103 | Final Rejection | — | Pending | Oct 04, 2023 |
| 18474544 | NASOGASTRIC DEVICE AND METHOD | Connecticut Children'S Medical Center | BRANDT, DAVID NELSON | 3783 | §101§103§112 | Non-Final OA | — | Pending | Sep 26, 2023 |
| 18351317 | ULTRASENSITIVE SENSING METHOD FOR DETECTION OF BIOMOLECULES | UNIVERSITY OF CONNECTICUT | EVANS, CHRISTOPHER RYAN | 1677 | §102§103§112 | Non-Final OA | — | Pending | Jul 12, 2023 |
| 18041271 | ANTI-SEED PNAS AND MICRORNA INHIBITION | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | MCCORMICK, CATHERINE LYNN | 1638 | §103 | Final Rejection | — | Pending | Feb 10, 2023 |
| 18017551 | BIOMEDICAL BIG DATA ANALYSIS PROGRAM | UNIVERSITY OF CONNECTICUT | PLAYER, ROBERT AUSTIN | 1686 | §101§103§112 | Non-Final OA | — | Pending | Jan 23, 2023 |
| 17881387 | ASSAY COMPOUND SCREENING | UNIVERSITY OF CONNECTICUT | FLINDERS, JEREMY C | 1684 | §101 | Final Rejection | — | Pending | Aug 04, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial88.0% of resolved applications prosecuted by Cantor Colburn LLP - Uconn were allowed, across 74,576 applications in USPTO records.
3.15 office actions per allowed application on average.
10 pending office actions as of October 2026, for 3 clients, before 10 examiners in 10 art units.
